Literature DB >> 21355734

Disposition of gamithromycin in plasma, pulmonary epithelial lining fluid, bronchoalveolar cells, and lung tissue in cattle.

Steeve Giguère1, Rose Huang, Thomas J Malinski, Paul M Dorr, Ronald K Tessman, Bruce A Somerville.   

Abstract

OBJECTIVE: To determine the disposition of gamithromycin in plasma, pulmonary epithelial lining fluid (PELF), bronchoalveolar lavage (BAL) cells, and lung tissue homogenate in cattle. ANIMALS: 33 healthy Angus calves approximately 7 to 8 months of age. PROCEDURES: Calves were randomly assigned to 1 of 11 groups consisting of 3 calves each, which differed with respect to sample collection times. In 10 groups, 1 dose of gamithromycin (6 mg/kg) was administered SC in the neck of each calf (0 hours). The remaining 3 calves were not treated. Gamithromycin concentrations in plasma, PELF, lung tissue homogenate, and BAL cells (matrix) were measured at various points by means of high-performance liquid chromatography with tandem mass spectrometry.
RESULTS: Time to maximum gamithromycin concentration was achieved at 1 hour for plasma, 12 hours for lung tissue, and 24 hours for PELF and BAL cells. Maximum gamithromycin concentration was 27.8 μg/g, 17.8 μg/mL, 4.61 μg/mL, and 0.433 μg/mL in lung tissue, BAL cells, PELF, and plasma, respectively. Terminal half-life was longer in BAL cells (125.0 hours) than in lung tissue (93.0 hours), plasma (62.0 hours), and PELF (50.6 hours). The ratio of matrix to plasma concentrations ranged between 4.7 and 127 for PELF, 16 and 650 for lung tissue, and 3.2 and 2,135 for BAL cells. CONCLUSIONS AND CLINICAL RELEVANCE: Gamithromycin was rapidly absorbed after SC administration. Potentially therapeutic concentrations were achieved in PELF, BAL cells, and lung tissue within 30 minutes after administration and persisted for 7 (PELF) to > 15 (BAL cells and lung tissue) days after administration of a single dose.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355734     DOI: 10.2460/ajvr.72.3.326

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  11 in total

1.  Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.

Authors:  S Crosby; B Credille; S Giguère; R Berghaus
Journal:  J Anim Sci       Date:  2018-04-14       Impact factor: 3.159

2.  Demonstration of the metaphylactic use of gamithromycin against bacterial pathogens associated with bovine respiratory disease in a multicentre farm trial.

Authors:  D Baggott; A Casartelli; F Fraisse; C Manavella; R Marteau; S Rehbein; M Wiedemann; S Yoon
Journal:  Vet Rec       Date:  2011-02-28       Impact factor: 2.695

3.  Pharmacokinetics of Tildipirosin in Plasma, Milk, and Somatic Cells Following Intravenous, Intramuscular, and Subcutaneous Administration in Dairy Goats.

Authors:  Juan Sebastián Galecio; Pedro Marín; Verónica Hernandis; María Botía; Elisa Escudero
Journal:  Pharmaceutics       Date:  2022-04-13       Impact factor: 6.525

4.  Pharmacokinetics in plasma and alveolar regions of a healthy calf intramuscularly administered a single dose of orbifloxacin.

Authors:  Tetsuro Kuramae; Shingo Ishikawa; Aki Kono; Seiji Hobo
Journal:  J Vet Med Sci       Date:  2022-01-28       Impact factor: 1.267

5.  Pharmacokinetics in plasma and alveolar regions of healthy calves subcutaneously administered a single dose of enrofloxacin.

Authors:  Tetsuro Kuramae; Konosuke Otomaru; Masaya Hirata; Shingo Ishikawa; Michiko Noguchi; Tomonobu Ikedo; Chie Horinouchi; Jun Hayashi; Keita Tsumagari; Seiji Hobo
Journal:  J Vet Med Sci       Date:  2020-07-19       Impact factor: 1.267

6.  Distribution of marbofloxacin within the bronchoalveolar region of healthy pigs.

Authors:  Moe Ijiri; Shingo Ishikawa; Yoshinori Jibiki; Masataka Miyazawa; Akane Senokuchi; Seiji Hobo
Journal:  J Vet Med Sci       Date:  2020-06-19       Impact factor: 1.267

7.  Intrapulmonary concentration of enrofloxacin in healthy calves.

Authors:  Konosuke Otomaru; Masaya Hirata; Tomonobu Ikedo; Chie Horinouchi; Michiko Noguchi; Shingo Ishikawa; Shun-Ichi Nagata; Seiji Hobo
Journal:  J Vet Med Sci       Date:  2015-12-13       Impact factor: 1.267

8.  The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.

Authors:  Zhixin Lei; Qianying Liu; Bing Yang; Saeed Ahmed; Jiyue Cao; Qigai He
Journal:  Oncotarget       Date:  2017-12-07

9.  Gamithromycin in swine: Pharmacokinetics and clinical evaluation against swine respiratory disease.

Authors:  Dietmar Hamel; Alexandra Richard-Mazet; Florian Voisin; Inge Böhne; Florence Fraisse; Renate Rauh; Rose Huang; Michael Kellermann; Laura Letendre; Pascal Dumont; Steffen Rehbein
Journal:  Vet Med Sci       Date:  2020-10-15

10.  Antimicrobial Resistance in Isolates from Cattle with Bovine Respiratory Disease in Bavaria, Germany.

Authors:  Alexander Melchner; Sarah van de Berg; Nelly Scuda; Andrea Feuerstein; Matthias Hanczaruk; Magdalena Schumacher; Reinhard K Straubinger; Durdica Marosevic; Julia M Riehm
Journal:  Antibiotics (Basel)       Date:  2021-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.